Risikoen for abstinenssymptomer kan afhænge af flere faktorer, herunder behandlingsvarighed og - dosering og hyppigheden af dosisreduktion.
The risk of withdrawal symptoms may be dependent on several factors including the duration and dose of therapy and the rate of dose reduction.